 <h1>Oxacillin Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to oxacillin: parenteral injection, parenteral powder for injection</i></p><p>Side effects include:</p><p>Hypersensitivity reactions; local reactions (phlebitis, thrombophlebitis); renal, hepatic, or nervous system effects with high dosage. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to oxacillin: injectable powder for injection, intravenous solution, oral capsule, oral powder for reconstitution</i></p><h3>Hypersensitivity</h3><p>Immediate allergic reactions usually occurred within 20 minutes of administration and ranged in severity from urticaria and pruritus to angioneurotic edema, laryngospasm, bronchospasm, hypotension, vascular collapse, and death; such immediate anaphylactic reactions were very rare and usually occurred after parenteral therapy but have occurred with oral therapy.  An accelerated immediate allergic reaction has occurred between 20 minutes and 48 hours after administration and has included urticaria, pruritus, and fever; although laryngeal edema, laryngospasm, and hypotension occasionally occurred, fatality was uncommon.</p><p></p><p>Delayed allergic reactions to penicillin therapy usually occurred after 48 hours and sometimes as late as 2 to 4 weeks after starting therapy.  Manifestations of this reaction included serum sickness-like symptoms (i.e., fever, malaise, urticaria, myalgia, arthralgia, abdominal pain) and various skin rashes.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Allergic reactions (included immediate and delayed reactions)</p><p><b>Rare</b> (0.01% to 0.1%): Anaphylactic shock</p><p><b>Very rare</b> (less than 0.01%): Anaphylactic shock resulting in death</p><p><b>Frequency not reported</b>: Immediate allergic reaction (included urticaria, pruritus, angioneurotic edema, laryngospasm, bronchospasm, hypotension, vascular collapse, death), accelerated immediate allergic reaction (included urticaria, pruritus, fever, laryngeal edema, laryngospasm, hypotension), delayed allergic reaction (included serum sickness-like reactions [i.e., fever, malaise, urticaria, myalgia, arthralgia, abdominal pain], various skin rashes), anaphylaxis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Onset of pseudomembranous colitis symptoms have occurred during and after antibiotic therapy.</p><p></p><p>Nausea, vomiting, diarrhea, stomatitis, black or hairy tongue, and gastrointestinal irritation have occurred, especially during oral penicillin therapy.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Pseudomembranous colitis, nausea, vomiting, diarrhea, stomatitis, black or hairy tongue, gastrointestinal irritation, Clostridium difficile-associated diarrhea<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Rash, urticaria, pruritus<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Neutropenia, bone marrow depression, agranulocytosis, leukopenia, thrombocytopenia, eosinophilia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Hepatotoxicity, abnormal liver function tests (mainly elevated AST levels), cholestatic jaundice, severe hepatitis, abnormal GGT serum levels<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Neurotoxic reactions (similar to those observed with penicillin G) have occurred with large IV doses, especially in patients with renal dysfunction.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Neurotoxic reactions, seizures<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Fever, abnormal alkaline phosphatase serum levels<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Renal tubular damage, interstitial nephritis, renal insufficiency, nephropathy, acute renal failure<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Hematuria, proteinuria<sup>[Ref]</sup></p><h3>Local</h3><p><b>Frequency not reported</b>: Thrombophlebitis, tissue necrosis after extravasation<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Severe hypokalemia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Bactocill (oxacillin)." SmithKline Beecham, Philadelphia, PA. </p><p id="ref_2">2. Dahlgren AF "Adverse drug reactions in home care patients receiving nafcillin or oxacillin." Am J Health Syst Pharm 54 (1997): 1176-9</p><p id="ref_3">3. Friedman RJ, Mayer IE, Galambos JT, Hersh T "Oxacillin-induced pseudomembranous colitis." Am J Gastroenterol 73 (1980): 445-7</p><p id="ref_4">4. Thomas E, Mehta JB "Pseudomembranous colitis due to oxacillin therapy." South Med J 77 (1984): 532-3</p><p id="ref_5">5. Maraqa NF,  Gomez MM,  Rathore MH,  Alvarez AM "Higher occurrence of hepatotoxicity and rash in patients treated with oxacillin, compared with those treated with nafcillin and other commonly used antimicrobials." Clin Infect Dis 34 (2002): 50-4</p><p id="ref_6">6. Fallon JA, Tall AR, Janis MG, Brauer MJ "Oxacillin-induced granulocytopenia." Acta Haematol 59 (1978): 163-70</p><p id="ref_7">7. Carpenter J "Neutropenia induced by semisynthetic penicillin." South Med J 73 (1980): 745-8</p><p id="ref_8">8. Slovick FT, Bamberger DM, Stark KR "Spontaneous clostridial myonecrosis in a man with drug-induced agranulocytosis." South Med J 82 (1989): 1272-4</p><p id="ref_9">9. Leventhal JM, Silken AB "Oxacillin-induced neutropenia in children." J Pediatr 89 (1976): 769-71</p><p id="ref_10">10. Brook I "Leukopenia and granulocytopenia after oxacillin therapy." South Med J 70 (1977): 565-6</p><p id="ref_11">11. Chu JY, O'Connor DM, Schmidt RR "The mechanism of oxacillin-induced neutropenia." J Pediatr 90 (1977): 668-9</p><p id="ref_12">12. Kahn JB "Oxacillin-induced agranulocytosis." JAMA 240 (1978): 2632</p><p id="ref_13">13. Ahern MJ, Hicks JE, Andriole VT "Neutropenia during high dose intravenous oxacillin therapy." Yale J Biol Med 49 (1976): 351-60</p><p id="ref_14">14. Passoff TL, Sherry HS "Oxacillin induced neutropenia. A case report." Clin Orthop 135 (1978): 69-70</p><p id="ref_15">15. Olans RN, Weiner LB "Reversible oxacillin hepatotoxicity." J Pediatr 89 (1976): 835-8</p><p id="ref_16">16. Tauris P, Jorgensen NF, Petersen CM, Albertsen K "Prolonged severe cholestasis induced by oxacillin derivatives." Acta Med Scand 217 (1985): 567-9</p><p id="ref_17">17. Dismukes WE "Oxacillin-induced hepatic dysfunction." JAMA 226 (1973): 861-3</p><p id="ref_18">18. Miller WI, Souney PF, Chang JT "Hepatic dysfunction following nafcillin and cephalothin therapy in a patient with a history of oxacillin hepatitis." Clin Pharm 2 (1983): 465-8</p><p id="ref_19">19. Trevenzoli M,  Cattelan AM,  Mencarelli R,  Meneghetti F "Severe hepatitis associated with oxacillin therapy." South Med J 96 (2003): 324-5</p><p id="ref_20">20. Halloran TJ, Clague MD "Hepatitis associated with high-dose oxacillin therapy." Arch Intern Med 139 (1979): 376-7</p><p id="ref_21">21. Deboever G "Cholestatic jaundice due to derivatives of oxacillin." Am J Gastroenterol 82 (1987): 483</p><p id="ref_22">22. Tillman DB, Oill PA, Guze LB "Oxacillin nephritis." Arch Intern Med 140 (1980): 1552</p><p id="ref_23">23. Fromm LA, Graham DL "Oxacillin-induced tissue necrosis." Ann Pharmacother 33 (1999): 1060-2</p><p id="ref_24">24. Schlaeffer F "Oxacillin-associated hypokalemia." Drug Intell Clin Pharm 22 (1988): 695-6</p><h2>More about oxacillin</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>Drug class: penicillinase resistant penicillins</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Joint Infection</li>
<li>Bacterial Infection</li>
<li>Bone infection</li>
<li>Endocarditis</li>
<li data-more-config-id="list-data-resources-conditions">... +5 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>